A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
PHASE3CompletedINTERVENTIONAL
Enrollment
596
Participants
Timeline
Start Date
February 29, 2000
Study Completion Date
May 31, 2003
Conditions
Kidney Failure, ChronicAnemia
Interventions
DRUG
epoetin alfa
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00261521 - A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients | Biotech Hunter | Biotech Hunter